A developing country perspective on vaccine-associated paralytic poliomyelitis

A developing country perspective on vaccine-associated paralytic poliomyelitis

When the Expanded Programme on Immunization was established and oral poliovirus vaccine (OPV) was introduced for developing countries to use exclusively, national leaders of public health had no opportunity to make an informed choice between OPV and the inactivated poliovirus vaccine (IPV). Today, a...

Full description

Bibliographic Details
Main Author:	John T. Jacob
Format:	Article
Language:	English
Published:	The World Health Organization 2004-01-01
Series:	Bulletin of the World Health Organization
Subjects:	Poliovirus vaccine, Oral/adverse effects Poliomyelitis/epidemiology Poliomyelitis/chemically induced Poliovirus vaccine, Inactivated/therapeutic use Poliovirus vaccine, Inactivated/economics Poliovirus/drug effects Immunization programs Developing countries
Online Access:	http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862004000100011

Similar Items

Vaccine-associated paralytic poliomyelitis in Russian Federation during the period of changes in vaccination schedule (2006-2013 y.y.)
by: O. E. Ivanova, et al.
Published: (2016-02-01)

PROBLEMS OF FINAL PHASE POLIOMYELITIS ERADICATION PROGRAMME
by: O. P. Chernyavskaya, et al.
Published: (2017-08-01)

Current polio status in the world
by: Elaine S. Lima, et al.
Published: (2021-07-01)

Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine
by: Kohler Kathryn A., et al.
Published: (2002-01-01)

Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
by: Joanne Hassan, et al.
Published: (2017-11-01)

Why the Furor about Polio?
by: Samuel Amo-Tachie
Published: (2023-02-01)

Promising opportunities to improve polio vaccines
by: E. E. Evreinova, et al.
Published: (2022-07-01)

Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014
by: Mohammadreza Shaghaghi, et al.
Published: (2016-10-01)

Circulating vaccine-derived polioviruses: current state of knowledge
by: Kew Olen M., et al.
Published: (2004-01-01)

Vaccine-Derived Polioviruses, Central African Republic, 2019
by: Marie-Line Joffret, et al.
Published: (2021-02-01)

Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission
by: Aylward R. Bruce, et al.
Published: (2004-01-01)

Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage
by: Ekaterina A. Korotkova, et al.
Published: (2020-09-01)

Update on Pakistan Polio Eradication Initiative
by: Maryam Riaz Tarar
Published: (2022-06-01)

Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception
by: Camila Cristina Martini Rodrigues, et al.
Published: (2022-11-01)

Etymologia: Poliomyelitis
by: Ronnie Henry
Published: (2019-08-01)

Measures counteracting 2016 spread of vaccine-derived poliomyelitis virus type 2 in Russian Federation
by: A. Yu. Popova, et al.
Published: (2020-04-01)

Inferring Numbers of Wild Poliovirus Excretors Using Quantitative Environmental Surveillance
by: Yuri Perepliotchikov, et al.
Published: (2021-08-01)

Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017
by: Nicholas C. Grassly, et al.
Published: (2018-11-01)

Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis
by: Guihua Tang, et al.
Published: (2018-11-01)

Poliomyelitis amidst the COVID-19 pandemic in Africa: Efforts, challenges and recommendations
by: Olivier Uwishema, et al.
Published: (2022-07-01)

Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial
by: Jingjun Qiu, et al.
Published: (2017-06-01)

The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame
by: Sue Ann Costa Clemens, et al.
Published: (2023-07-01)

Nível de imunidade contra a poliomielite em um grupo de crianças vacinadas de acordo com o calendário oficial de imunização (São Paulo, Brasil) Level of immunity to poliomyelitis in a group of children vaccinated according to the current official vaccination scheme (S. Paulo, Brazil)
by: Victorio Barbosa, et al.
Published: (1978-09-01)

Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey
by: Gabriel Trueba, et al.
Published: (2022-07-01)

STUDY OF IMMUNITY TO POLIOVIRUSES ON CERTAIN "SILENT" TERRITORIES OF RUSSIA
by: N. I. Romanenkova, et al.
Published: (2014-06-01)

Stopping poliovirus vaccination after eradication: issues and challenges
by: D.J. Wood, et al.

Lessons from Vaccine-Related Poliovirus in Israel, UK and USA
by: T. Jacob John, et al.
Published: (2022-11-01)

Poliomyelitis: Current Status in Iran and Worldwide
by: Rahim Vakili, et al.
Published: (2015-06-01)

Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence
by: Francis Delpeyroux, et al.
Published: (2011-08-01)

The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases
by: Kouichi Kitamura, et al.
Published: (2021-07-01)

Photo Quiz
by: Davide Orsini, et al.
Published: (2022-03-01)

Cost analysis of post-polio certification immunization policies
by: Sangrujee Nalinee, et al.
Published: (2004-01-01)

Religious Opposition to Polio Vaccination
by: Haider J. Warraich
Published: (2009-06-01)

A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
by: Takashi Nakano, et al.
Published: (2018-12-01)

Protease-Independent Production of Poliovirus Virus-like Particles in Pichia pastoris: Implications for Efficient Vaccine Development and Insights into Capsid Assembly
by: Lee Sherry, et al.
Published: (2023-02-01)

The impact of different IPV-OPV sequential immunization programs on hepatitis A and hepatitis B vaccine efficacy
by: Shiyi Chen, et al.
Published: (2022-01-01)

Preparation and Characterization of a Neutralizing Monoclonal Antibody against Poliovirus Type 1 (Mahoney Strain)
by: Sina Soleimani, et al.
Published: (2019-01-01)

Current knowledge about Post-Polio Syndrome (PPS)
by: Julita Poleszak, et al.
Published: (2019-09-01)

Potential Use of Antiviral Agents in Polio Eradication
by: Armando M. De Palma, et al.
Published: (2008-04-01)

Global epidemiology of vaccine-derived poliovirus 2016–2021: A descriptive analysis and retrospective case-control study
by: Yi An Lai, et al.
Published: (2022-08-01)